Hosted on MSN22m
Four regimens fail endpoints simultaneously in HEALEY ALS trial
ALS candidates from Biohaven, Prilenia, Clene and UCB have all failed to halt disease progression versus placebo in the US-wide platform trial.
Accelerated drug-testing platform for ALS paves way for therapeutic innovation
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.
News Medical on MSN1d
Groundbreaking ALS platform trial accelerates research and drug testing
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.
CBS News20d
Matthew Perry Foundation and Massachusetts General Hospital team up to fight addiction
Massachusetts General Hospital on Tuesday announced the creation of the "Matthew Perry Foundation Fellowship in Addiction Medicine." The inaugural fellow is Dr. Sarah "SK" Kler, who will join an ...